Quarterly Result29 Oct 2026, 10:31 pm
Sudarshan Pharma Declares Unaudited Q2 FY27 Financial Results
AI Summary
Sudarshan Pharma Industries Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board of Directors approved these results along with the Auditors' Limited Review Report at a meeting held today. The filing was made pursuant to Regulation 33 of the SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Key Highlights
- Unaudited financial results for Q2 FY27 declared.
- Both standalone and consolidated results are available.
- Results approved by the Board of Directors.
- Auditors' Limited Review Report also submitted.
- Filing complies with SEBI Listing Regulations.
Price Impact
More from SUDARSHAN